About 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol
1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol (PubChem CID 137407483) has the molecular formula C20H26BrN3O
and a molecular weight of 404.35 g/mol. Its IUPAC name is 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol.
Analyze 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol?
The IUPAC name of 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol (CID 137407483) is 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol.
What is the SMILES notation for 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol?
The canonical SMILES for 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol is CC(C)(C)C(O)c1ccc(N2CCN(c3ccc(Br)cc3)CC2)cn1.
What is the InChIKey of 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol?
The InChIKey is NJWCYXQTFNXBSX-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H26BrN3O/c1-20(2,3)19(25)18-9-8-17(14-22-18)24-12-10-23(11-13-24)16-6-4-15(21)5-7-16/h4-9,14,19,25H,10-13H2,1-3H3.
What are the key properties of 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol?
1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol has a molecular weight of 404.35 g/mol, XLogP of 4.25, 3 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[5-[4-(4-bromophenyl)piperazin-1-yl]-2-pyridinyl]-2,2-dimethylpropan-1-ol is sourced from PubChem (CID 137407483), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).